Bio-behavioral Interventions for Cardiovascular Diseases Rehabilitation: A Systematic Review on Heart Rate

Valeria Carola1, Valeria Gigli2, Filippo Cellucci3

  • 1Department of Dynamic and Clinical Psychology, and Health Studies, Sapienza University of Rome, Via degli Apuli, 1, 00185, Rome, Italy. valeria.carola@uniroma1.it.

Insights

Heart rate variability biofeedback (HRVBF) and cardioprotective diets show promise for cardiovascular disease (CVD) rehabilitation. However, more research is needed to establish their effectiveness in clinical settings for secondary prevention.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Rehabilitation

Background:

  • Cardiovascular diseases (CVD) are a major global health burden, necessitating effective secondary prevention and rehabilitation strategies.
  • Noninvasive interventions like heart rate variability biofeedback (HRVBF) and cardioprotective diets are explored for their potential benefits.
  • The established efficacy of these interventions within cardiac rehabilitation and secondary prevention contexts requires further systematic evaluation.

Purpose of the Study:

  • To systematically review the evidence for HRVBF and heart-healthy dietary patterns in CVD relapse prevention and rehabilitation.
  • To assess the potential role of these noninvasive strategies, particularly within hospital-based and postoperative settings.
  • To identify gaps in current research and guide future clinical protocol development.

Main Methods:

  • Systematic literature search conducted in Scopus and PubMed, adhering to PRISMA guidelines.
  • Focus on studies evaluating heart rate variability biofeedback (HRVBF) and cardioprotective dietary patterns (e.g., Mediterranean, omega-3 fatty acids).
  • Inclusion criteria prioritized evidence relevant to patients with established CVD or undergoing cardiac rehabilitation.

Main Results:

  • Heart rate variability biofeedback (HRVBF) shows potential to improve autonomic regulation, reduce psychological distress, and decrease hospital stays.
  • Dietary interventions, especially Mediterranean-style diets and omega-3 fatty acids, may reduce inflammation and modulate cardiovascular risk markers.
  • Limited evidence currently supports the widespread integration of HRVBF and specific dietary patterns into established CVD rehabilitation protocols.

Conclusions:

  • HRVBF and cardioprotective diets offer promising avenues for noninvasive cardiovascular rehabilitation and secondary prevention.
  • Further research with structured protocols is essential to confirm their efficacy, particularly in immediate postoperative phases or post-acute cardiac events.
  • Standardization of study designs is crucial for enhancing the generalizability of findings in clinical settings.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
6.1K
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
786
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252